Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2007-04-27
2008-11-11
Eyler, Yvonne (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C560S028000, C560S041000, C564S342000, C564S343000, C564S133000, C564S134000, C564S182000
Reexamination Certificate
active
07449603
ABSTRACT:
Provided is a process for preparing Cinacalcet, (R)-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine and intermediates thereof.
REFERENCES:
patent: 4966988 (1990-10-01), Schinski et al.
patent: 5648541 (1997-07-01), Van Wagenen et al.
patent: 6011068 (2000-01-01), Nemeth et al.
patent: 6031003 (2000-02-01), Nemeth et al.
patent: 6211244 (2001-04-01), Van Wagenen et al.
patent: 6313146 (2001-11-01), Van Wagenen et al.
patent: 2005/0147669 (2005-07-01), Lawrence et al.
patent: 2005/0234261 (2005-10-01), Wilken et al.
patent: 2006/0276534 (2006-12-01), Martin et al.
patent: WO 2006/125026 (2006-11-01), None
Devasher et al., “Aqueous-Phase, Palladium-catalyzed cross-coupling of aryl bromides under mild conditions, using water soluable, sterically demanding alkylphosphines”, Journal of Organic Chemistry, American Chemical Society, vol. 69, 2004, pp. 7919-7927.
Anonymous, “N-[1-(R)-(-)-(1-naphthyl)]-3-[3-[3-(trifluoromethyl)phenyl]-1-aminopropane hydrochloride”, IP.com Journal, May 23, 2005, XPO002424259.
“Sensipar (Cinacalcet HCI) Tablets” Summary Basis of Approval of New Drug Application #21-688 By FDA, (2004).
Iqbal et al., “Cinacalcet Hydrochloride”IDrugs, vol. 6, No. 6, p. 587-592, (2003).
Snyder et al.,Introduction To Modern Liquid Chromatography, 2nd Ed., (1979), pp. 549-572, John Wiley & Sons, Inc.
Strobel et al.,Chemical Instrumentation: A Systematic Approach, 3rd Ed., (1989), pp. 391-393, 879-894, 922-925, 953.
Database Belistein; Belistein Institute for Organic Chemistry, Frankfurt-Main, DE; XP002451055 (& Pharmazie, vol. 59, No. 10, 2004, pp. 744-752).
“Cinacalcet Hydrochloride: Treatment of Hyperparathyroidism”, Drugs of the Future (2002) 27 (9):831-836.
Wang et al., “Synthesis of Cinacalcet congeners”, Tetrahedron Letters (2004) 45:8355-8358.
Eyler Yvonne
Katakam Sudhakar
Kenyon & Kenyon LLP
Teva Pharmaceutical Industries Ltd.
LandOfFree
Process for the preparation of cinacalcet base does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of cinacalcet base, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of cinacalcet base will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4027406